Aether Biomedical Raises $5.8M in Series A Funding

Aether Biomedical

Aether Biomedical, a Poznań, Poland-based biotech company creating bionic prosthetics, raised $5.8M in Series A funding.

The round was led by J2 Ventures and Story Ventures with participation from existing partner, Chiratae Ventures.

The company intends to use the funds to expand manufacturing options for their flagship product, The Zeus hand, and advance research and development.

Led by CEO Dhruv Agrawal, Aether is building human-inspired machines, starting with intelligent prosthetic hand. Its flagship product, the Zeus hand, is a bionic hand for upper limb amputees. It uses neural signals, Internet of Things (IoT), machine learning and deep learning to give users more autonomy and ease in their daily lives.

In 2021, Aether Biomedical extended its global reach by establishing its U.S. headquarters in Chicago, IL. This expansion complements their international presence in Poland and India.

Since their inception in 2017, Aether has created and distributed hundreds of Zeus hands. Thus far in 2023, the company has distributed 250+ Zeus hands, with plans for distributing products to war-ridden territories including Ukraine.